The Small Business Innovation Research (SBIR) Phase IIB grant from the National Science Foundation (NSF) adds to the $650,000 received in NSF SBIR Phase I.
Under an agreement with Life Technologies, Rheonix is developing capabilities for the in vitro diagnostics market and will supply its CARD technology to the firm for an automated testing platform in markets such as food testing.
A raw sample is placed on the Rheonix CARD, which the automated platform runs through the process of sample extraction, DNA purification, amplification and detection.
“The added funding by NSF further validates the scientific merit of our platform,” said Tony Eisenhut, president of Rheonix.
“In addition, having a strategic partner of the stature of Life Technologies was a definite benefit during our discussions with NSF.”